Eye Diseases
Diagnosis and Treatments
Follow social networks!
International Eye
International Eye
Payment Options
Retinal Diseases
Homepage  /  Eye Diseases  /  Retinal Diseases
  • Methods of Diagnosis and Treatment of Retinal Diseases
  • What Retinal Diseases?
  • How is it diagnosed?
  • Treatment of Retinal Diseases
  • Intraocular Drug Applications
  • Drug injections into the eye have been used for more than 30 years. Today, this method of treatment has expanded the application domain.

    Anti-VEGF drug application;
    Vascularized placental vascular endothelial growth factor VEGF, which stands for normal wound healing, natural physiological functions, such as bone growth is a substance. Retinal endothelial cells, endothelial cells higher than the number of other VEGF receptors. Binding to specific receptors on vascular endothelial cells, VEGF increases vascular permeability. Anti-VEGF agents are substances that inhibit the formation of new blood vessels. Age-related macular degeneration (AMD), diabetic retinopathy, retinal vascular occlusion, and in some diseases, such as developing new blood vessels (neovascularization) that cause bleeding problems may lead to progressive blindness. Anti-VEGF agents utilized in the treatment of these pathologies.

    Vasculogenesis, called the pioneers of endothelial cell differentiation in the embryo is called angiogenesis and blood vessel formation and plays a role in the advanced stages of the formation of new blood vessels vessels. The formation of new blood vessels can also be physiological as well as pathological this. Would lead to ischemia or inflammation of any cases (age-related macular Degeneration, diabetic retinopathy, neonatal retinopathy, retinal vascular occlusion, etc.) increases the release of the retina and the formation of new blood vessels can lead to unwanted places and structures. Vascular Endothelial Growth Factor (VEGF), eye cells and new blood vessels that make up a protein secreted by the case of illness.

    Anti-VEGF drugs are administered by injection into the eye. The eye drop anesthesia numbed during application. The process is painful, short-term and minimal.

    Age-related macular degeneration with photodynamic therapy administered anti-VEGF drugs. In today's approach to treatment and one month after application of the anti-VEGF drugs is repeated as needed.

    Anti-VEGF drugs prevent the formation of blood vessels and the development of new blood vessels because they provide a set of regression of existing vessels, retinal vascular pathology are injected into the eye (proliferative diabetic retinopathy, retinal vein occlusion root Eales disease, etc.). It is also useful in the treatment of diabetic macular edema due to decreasing vascular permeability.

    Each method of treatment, as well as some of the complications of intravitreal injection for the treatment of rare, can occur. The most important complication of endophthalmitis (intraocular inflammation) and medication given 0.1-1% was observed when. In addition, the very low rate of increase in intraocular pressure, cataract and retinal detachment include such risks.

    Intravitreal Steroid Injection;
    Corticosteroids have long been used in the treatment of ocular inflammatory diseases. Increase the access of drug to the target organ and to decrease the side effects of systemic drugs are preferred for locally. Ocular corticosteroids, topical, subconjunctival, retrobulbar injections directly into the eye commonly used in applications with a high concentration of the therapeutic effect of the drug increases.

    Triamcinolone Acetonide is a kind of derivative of cortisone, given by injection into the eye or behind the eye. In general, a dose of 4 mg intravitreal used. Yellow spot disease, age type of photodynamic therapy can be combined with anti-VEGF drugs. Considered as an alternative treatment method.

    Intravitreal triamcinolone acetonide (IVTA), diabetic retinopathy, intraocular fibrovascular RETINOPATHY, uveitis, age-related macular degeneration (AMD) and choroidal neovaskülarizasyonlarda, hypotonic, macular edema due to retinal vein occlusion, and pseudophakic cystoid macular edema is used.

    Some complications may occur after intravitreal triamcinolone acetonide injection. '' The most important complication is endophthalmitis (intraocular inflammation) and medication given 0.1% was observed in less than. In addition, a temporary increase in intraocular pressure, cataract and retinal detachment include such risks.
  • Macular Degeneration (Yellow Spot Disease) Treatment
  • Eye angiography (FFA) and Oct
  • Treatment of Retinal Detachment
  • Detachment Surgery Risks?
  • Frequently Asked Questions
  • Hospital for Special INTERNATIONAL EYE © 2002-2012 All rights reserved.
    web design medyatör
    İSO 9001:2000
    International Eye